Cargando…

Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases

BACKGROUND: Hyperferritinemic syndromes are systemic inflammatory disorders characterized by a dysfunctional immune response, which leads to excessive activation of the monocyte-macrophage system with hypercytokinemia and may pursue a rapidly fatal course. CASE PRESENTATION: We describe two patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papa, Riccardo, Natoli, Valentina, Caorsi, Roberta, Minoia, Francesca, Gattorno, Marco, Ravelli, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353681/ https://www.ncbi.nlm.nih.gov/pubmed/32653009 http://dx.doi.org/10.1186/s12969-020-00450-9

Ejemplares similares

Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome
por: Torene, Rebecca, et al.
Publicado: (2017)

The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
por: Caorsi, Roberta, et al.
Publicado: (2013)

Treatment of refractory Yao syndrome with canakinumab
por: Brailsford, Caroline J., et al.
Publicado: (2022)

Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
por: Caorsi, R, et al.
Publicado: (2011)

COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
por: Colafrancesco, Serena, et al.
Publicado: (2020)

Syndrome of Undifferentiated Recurrent Fever (SURF): An Emerging Group of Autoinflammatory Recurrent Fevers
por: Papa, Riccardo, et al.
Publicado: (2021)

Canakinumab for refractory RA: a case report
por: Marketos, Nikolaos, et al.
Publicado: (2018)

Hyperferritinemic Sepsis: An Opportunity for Earlier Diagnosis and Intervention?
por: Halstead, E. Scott, et al.
Publicado: (2016)

Chronic active EBV infection mimicking periodic fever syndromes: a new challenge for the paediatrician
por: Caorsi, Roberta, et al.
Publicado: (2014)

A child with a novel ACAN missense variant mimicking a septic arthritis
por: Florio, Angelo, et al.
Publicado: (2019)

COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
por: Perricone, Carlo, et al.
Publicado: (2020)

Gene expression profiling in understanding the molecular pathogenesis of and response to canakinumab therapy in traps
por: Gattorno, M, et al.
Publicado: (2014)

Canakinumab for the treatment of different refractory autoinflammatory disorders
por: Grein, Ingrid HR, et al.
Publicado: (2014)

OR10-006 - Canakinumab in patients with TRAPS
por: Lachmann, HJ, et al.
Publicado: (2013)

The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome
por: Rosário, Cristina, et al.
Publicado: (2013)

Cardiovascular Manifestations in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 According to Age
por: Campanello, Claudia, et al.
Publicado: (2022)

A Case of Hyperimmunoglobulinemia D Syndrome Successfully Treated with Canakinumab
por: Tsitsami, Elena, et al.
Publicado: (2013)

Fulminant encephalopathy in a child with hyperferritinemic sepsis: a case report
por: Huang, Lilin, et al.
Publicado: (2020)

Incidence rate of MIS‐C in paediatrics: A good reason to vaccinate children against SARS‐CoV‐2
por: Castagnola, Elio, et al.
Publicado: (2021)

Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
por: Mariani, Marcello, et al.
Publicado: (2022)

Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?
por: Ruscitti, Piero, et al.
Publicado: (2023)

Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
por: Ruscitti, Piero, et al.
Publicado: (2020)

Long-term efficacy of etanercept in ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2014)

A case of Schnitzler’s syndrome without monoclonal gammopathy successfully treated with canakinumab
por: Fujita, Yuya, et al.
Publicado: (2021)

Monogenic polyarteritis: the lesson of ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2016)

Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment
por: Alpa, Mirella, et al.
Publicado: (2015)

Timely Recognition and Early Multi-Step Antinflammatory Therapy May Prevent ICU Admission of Patients With MIS-C: Proposal for a Severity Score
por: Brisca, Giacomo, et al.
Publicado: (2021)

Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature
por: Borgia, Paola, et al.
Publicado: (2021)

Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review
por: Finetti, Martina, et al.
Publicado: (2016)

Secondary Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, and Hyperferritinemic Sepsis-Induced Multiple-Organ Dysfunction Syndrome in the Pediatric ICU
por: Carcillo, Joseph A., et al.
Publicado: (2018)

PReS-FINAL-2237: The diagnostic challenge of osteolytic bone lesions in autoinflammatory diseases: a case report
por: Caorsi, R, et al.
Publicado: (2013)

Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis
por: Fan, Zhenziang, et al.
Publicado: (2023)

An Update on Familial Mediterranean Fever
por: Lancieri, Maddalena, et al.
Publicado: (2023)

Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children
por: Signa, Sara, et al.
Publicado: (2020)

Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
por: Gattorno, Marco, et al.
Publicado: (2017)

Expedited Desensitization to Canakinumab
por: Sanan, Neha, et al.
Publicado: (2020)

Case report on the use of canakinumab for treatment of recurrent fevers and proteinuria in refractory systemic lupus erythematosus
por: Yavari, Kimia, et al.
Publicado: (2023)

Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?
por: Matucci-Cerinic, Caterina, et al.
Publicado: (2021)

PW02-010 - The diagnostic challenge of bone lesions in AID
por: Caorsi, R, et al.
Publicado: (2013)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3jsmj69430lj5j433jjlfnq12d